Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Inventory (2021 - 2026)

ADC Therapeutics has reported Change in Inventory over the past 6 years, most recently at -$16000.0 for Q1 2026.

  • Quarterly results put Change in Inventory at -$16000.0 for Q1 2026, down 105.23% from a year ago — trailing twelve months through Mar 2026 was $2.1 million (down 40.59% YoY), and the annual figure for FY2025 was $2.4 million, down 36.13%.
  • Change in Inventory reached -$16000.0 in Q1 2026 per ADCT's latest filing, down from $853000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $9.7 million in Q4 2022 and bottomed at -$518000.0 in Q2 2024.
  • Median Change in Inventory over the past 5 years was $516000.0 (2025), compared with a mean of $1.3 million.
  • Peak annual rise in Change in Inventory hit 468211.73% in 2022, while the deepest fall reached 26714.29% in 2022.
  • Over 5 years, Change in Inventory stood at $9.7 million in 2022, then crashed by 101.73% to -$167000.0 in 2023, then skyrocketed by 1775.45% to $2.8 million in 2024, then plummeted by 69.51% to $853000.0 in 2025, then plummeted by 101.88% to -$16000.0 in 2026.
  • Business Quant data shows Change in Inventory for ADCT at -$16000.0 in Q1 2026, $853000.0 in Q4 2025, and $516000.0 in Q3 2025.